Evidence map›Paper›PMID 36430156›Full record

ArticleInternational journal of molecular sciences2022

FOXO1 Is a Key Mediator of Glucocorticoid-Induced Expression of Tristetraprolin in MDA-MB-231 Breast Cancer Cells.

Do Yong Jeon, So Yeon Jeong, Ju Won Lee, Jeonghwan Kim, Jee Hyun Kim, Hun Su Chu, Won Jin Jeong, Byung Ju Lee, Byungyong Ahn, Junil Kim and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Do Yong JeonDepartment of Biological Sciences, University of Ulsan, Ulsan 44610, Korea.
So Yeon JeongDepartment of Biological Sciences, University of Ulsan, Ulsan 44610, Korea.
Ju Won LeeDepartment of Biological Sciences, University of Ulsan, Ulsan 44610, Korea.
Jeonghwan KimSchool of System Biomedical Science, Soongsil University, Seoul 06978, Korea.
Jee Hyun KimRopheLBio, B102, Seoul Forest M Tower, Seoul 04778, Korea.
Hun Su ChuRopheLBio, B102, Seoul Forest M Tower, Seoul 04778, Korea.
Won Jin JeongRopheLBio, B102, Seoul Forest M Tower, Seoul 04778, Korea.
Byung Ju LeeDepartment of Biological Sciences, University of Ulsan, Ulsan 44610, Korea.
Byungyong AhnDepartment of Food Science and Nutrition, University of Ulsan, Ulsan 44610, Korea.ORCID 0000-0002-9871-5180
Junil KimSchool of System Biomedical Science, Soongsil University, Seoul 06978, Korea.
Seong Hee ChoiRopheLBio, B102, Seoul Forest M Tower, Seoul 04778, Korea.
Jeong Woo ParkDepartment of Biological Sciences, University of Ulsan, Ulsan 44610, Korea.
University of Ulsan · KRSoongsil University · KR

Funding

National Research Foundation of Korea NRF- 2014R1A6A1030318
6 · The paper itself

Abstract

The mRNA destabilizing factor tristetraprolin (TTP) functions as a tumor suppressor by down-regulating cancer-associated genes.

Indexed as

NeoplasmsTristetraprolinGlucocorticoidsPhosphatidylinositol 3-KinasesReceptors, GlucocorticoidGlucocorticoidsPhosphatidylinositol 3-KinasesReceptors, GlucocorticoidTristetraprolinbetamethasonecancer cellsdexamethasoneFOXO1tristetraprolin

Identifiers

PMID36430156
PMCPMC9693238
OpenAlexW4308581270

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.